CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of early drug development software solutions, announced today that The University of Texas M. D. Anderson Cancer Center (M. D. Anderson) has purchased Provantis 8™ for its research facilities in central Texas.
